Exelixis, Inc. share price logo

Exelixis, Inc. Share Price

NASDAQ: EXEL

Mid Cap

$39.16

+0.09

(+0.23%)

as on

Exelixis, Inc. Stock Performance

as on September 13, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $38.77
    $39.27
    downward going graph

    1.00%

    Downside

    0.28%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $25.17
    $49.62
    downward going graph

    35.72%

    Downside

    26.71%

    Upside

    downward going graph

Exelixis, Inc. share price movements today

Previous Close
$39.07
Open
$38.77
Volume
2.2M
Day's Low - High
$38.77 - $39.27
52 Week Low - High
$25.17 - $49.62

Exelixis, Inc. Historical Returns

1 Month Return
+ 2.95 %
3 Month Return
-6.49 %
1 Year Return
+ 48.5 %
3 Year Return
+ 117.42 %
5 Year Return
+ 79.8 %

Exelixis, Inc. Stock Fundamentals & Key Indicators

Check Exelixis, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.5B

EPS (TTM)

2.7082

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.16%

PE Ratio (TTM)

18.78

Industry PE ratio

10.127857142857144

P/B Ratio

18.7837

PEG Ratio

2.2685

EBITDA

781.5M

Revenue (TTM)

2.2B

Profit Margin

27.01%

Return On Equity TTM

29.00%

Exelixis, Inc. Stock Valuation

Track how Exelixis, Inc. P/E has moved over time to understand its valuation trends.

Exelixis, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (15.15x)

September 30, 2024

Industry (10.13x)

September 12, 2025

Today (18.78x)

September 12, 2025

Highest (122.74x)

April 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 18.78x

Exelixis, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Exelixis, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$10.5B79.8%18.7827.01%
BUY$61.5B282.7%-505.15-12.96%
NA$37.7BNANA-3.89%
BUY$101.9B54.04%28.2431.86%
BUY$59.2B2.03%14.3331.37%

Stock Returns calculator for Exelixis, Inc. Stock including INR - Dollar returns

The Exelixis, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Exelixis, Inc. investment value today

Current value as on today

₹1,53,956

Returns

₹53,956

(+53.96%)

Returns from Exelixis, Inc. Stock

₹48,841 (+48.84%)

Dollar Returns*

₹5,115 (+5.12%)

Analyst Recommendation on Exelixis, Inc. Stock

Based on 26 analysts

BUY

76.92%

Buy

19.23%

Hold

3.85%

Sell

Based on 26 analysts, 76.92% of analysts recommend a 'BUY' rating for Exelixis, Inc.. Average target price of $44.06

Exelixis, Inc. Share Price Target

Get share price movements and forecasts by analysts on Exelixis, Inc..

What analysts predicted

11.12%UPSIDE

Target Price

$44.06

Current Price

$39.16

Analyzed by

26 Analysts

Target

$44.06

Exelixis, Inc. target price $44.06, a slight upside of 11.12% compared to current price of $39.16. According to 26 analysts rating.

Exelixis, Inc. Stock's Interest Amongst Investors

Search interest for Exelixis, Inc. Stock has increased by 23% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:23% versus previous 30 day period

Exelixis, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
408
469
471
479
425
637
539
566
555
568
Gross Profit
394
452
453
457
403
619
522
546
536
548
Operating Income
21
77
-17
81
29
275
136
163
186
213
EBITDA
28
83
-11
88
68
283
195
171
194
237
Interest Expense
26
-
-
26
-
-
-
-
-
-
Depreciation
6
6
6
6
6
7
7
7
7
7
Income Before Tax
48
100
5
103
49
292
154
184
205
230
Income Tax Expense
8
19
4
17
11
66
36
44
46
45
Net Income
40
81
1
85
37
226
117
139
159
184
Net Profit Margin
9.79%
17.28%
0.22%
17.83%
8.78%
35.49%
21.87%
24.68%
28.74%
32.53%

Exelixis, Inc. Annual Profit & Loss

All numbers in Millions USD

Jan 2019
Dec 2019
Jan 2020
Dec 2020
Jan 2021
Dec 2021
Jan 2022
Dec 2022
Dec 2023
Dec 2024
Total Revenue
853
967
967
987
987
1,434
1,434
1,611
1,830
2,168
Gross Profit
-
934
-
951
-
1,382
-
1,553
1,757
2,092
Operating Income
-
369
-
110
-
286
-
201
170
604
EBITDA
-
377
-
119
-
300
-
222
196
718
Interest Expense
-
-
-
-
-
-
-
53
-
-
Depreciation
-
8
-
9
-
13
-
20
25
28
Income Before Tax
-
398
-
130
-
294
-
234
257
681
Income Tax Expense
-
77
-
19
-
63
-
52
49
160
Net Income
690
321
321
111
111
231
231
182
207
521
Net Profit Margin
80.82%
33.17%
33.17%
11.32%
11.32%
16.10%
16.10%
11.31%
11.35%
24.04%

Exelixis, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
81
1
85
37
226
117
139
159
184
Operating Cash Flow
120
117
10
68
119
271
240
211
48
Investing Cash Flow
-73
34
61
111
81
-217
-93
49
248
Financing Cash Flow
-124
-219
-206
-184
-262
5
-188
-294
-316
Change in Cash
-77
-67
-133
-3
-39
59
-40
-33
-19

Exelixis, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-70
154
690
321
111
231
182
207
521
Operating Cash Flow
206
165
415
526
208
400
362
333
699
Investing Cash Flow
-216
35
-297
-587
-131
-42
-524
-26
-116
Financing Cash Flow
19
-169
9
12
-25
-14
0
-546
-628
Change in Cash
10
31
127
-47
52
343
-161
-239
-45

Global Institutional Holdings in Exelixis, Inc.

Funds
Holdings
BlackRock Inc
11.28%
Vanguard Group Inc
10.65%
Farallon Capital Management, L.L.C.
8.37%
Renaissance Technologies Corp
5.51%
State Street Corp
4.38%

Insights on Exelixis, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, EXEL stock has moved up by 47.7%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, 117.97M → 184.84M (in $), with an average increase of 13.9% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 555.44M → 568.26M (in $), with an average increase of 2.3% per quarter

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, EXEL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 76.6% return, outperforming this stock by 28.9%

About Exelixis, Inc.

exelixis is a biopharmaceutical company focused on developing and commercializing small molecule therapies with the potential to improve the treatment of cancer. over the past decade, we have established a broad development platform, laying the foundation for our continued efforts to bring new therapies for cancer to patients in need. our first commercial product, cometriq® (cabozantinib), received its initial regulatory approval in late 2012. we are committed to excellence in all aspects of our business and are dedicated to improving the care of, and outcomes for, patients with cancer. for more information about the company and potential job opportunities, please visit our website at www.exelixis.com.
OrganisationExelixis, Inc.
Headquarters1851 Harbor Bay Parkway, Alameda, CA, United States, 94502
IndustryHealth Technology
CEODr. Michael M. Morrissey Ph.D.
E-voting on sharesClick here to vote

Key Management of Exelixis, Inc.

Name

Title

Mr. Jeffrey J. Hessekiel J.D.

Executive VP & General Counsel

Dr. William Berg M.D.

Senior Vice President of Medical Affairs

Dr. Stefan Krauss Ph.D.

VP & Head of Business Development

Dr. Dana T. Aftab Ph.D.

Executive Vice President of Research & Development

Ms. Susan T. Hubbard

Executive Vice President of Public Affairs & Investor Relations

Dr. Anne Champsaur M.D.

Senior Vice President of Drug Safety

Mr. Patrick Joseph Haley M.B.A.

Executive Vice President of Commercial

Dr. Stelios Papadopoulos Ph.D.

Co-Founder & Independent Chair of the Board

Dr. Michael M. Morrissey Ph.D.

CEO, President & Director

Mr. Christopher J. Senner

Executive VP & CFO

FAQs

What is Exelixis, Inc. share price today?

Exelixis, Inc. share price today is $39.16 as on at the close of the market. Exelixis, Inc. share today touched a day high of $39.27 and a low of $38.77.

What is the 52 week high and 52 week low for Exelixis, Inc. share?

Exelixis, Inc. share touched a 52 week high of $49.62 on and a 52 week low of $25.17 on . Exelixis, Inc. stock price today i.e. is closed at $39.16,which is 21.08% down from its 52 week high and 55.56% up from its 52 week low.

What is Exelixis, Inc.'s market capitalisation today?

Exelixis, Inc. market capitalisation is $0.01T as on .

How to invest in Exelixis, Inc. Stock (EXEL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Exelixis, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Exelixis, Inc. Shares that will get you 0.0383 shares as per Exelixis, Inc. share price of $39.16 per share as on September 13, 2025 at 1:29 am IST.

What is the minimum amount required to buy Exelixis, Inc. Stock (EXEL) from India?

Indian investors can start investing in Exelixis, Inc. (EXEL) shares with as little as ₹88.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹882.50 in Exelixis, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Exelixis, Inc. share’s latest price of $39.16 as on September 13, 2025 at 1:29 am IST, you will get 0.2554 shares of Exelixis, Inc.. Learn more about fractional shares .

What are the returns that Exelixis, Inc. has given to Indian investors in the last 5 years?

Exelixis, Inc. stock has given 79.8% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?